Kuliah pakar Prodi DIII Farmasi STIKes Karsa Husada Garut oleh Dr. TPH. Simorangkir (CPOB)

Fundamental Concepts in Pharmaceutical Industry
📌 The essential components for building a pharmaceutical facility include hardware (buildings, equipment, tools), software (guidelines, regulations like CPob), and brainware (personnel, including pharmaceutical and technical staff).
👩‍🔬 The primary roles and functions for pharmaceutical/technical staff are in Production, Quality Control (QC), and Quality Assurance (QA).
⚙️ Production involves processing and packaging, while QC handles sampling, testing, specification, inspection, and monitoring.

CPob (Good Manufacturing Practices) as a Guideline
🧭 The ultimate goal of understanding CPob is to consistently produce high-quality medicine (Safe, Acceptable, Efficacious - SAE).
💡 CPob acts as a compass guiding operations, structured around the core principles: Elimination (E), Validation (V), and Documentation (D).
🚫 Elimination focuses on minimizing errors, weaknesses, and contaminants related to the 12 aspects of CPob (e.g., personnel, facilities, equipment).

Core Responsibilities and Industry Structure
📈 Pharmaceutical quality requires balancing economic aspects (profit margin) with social aspects (sustainability of drug supply).
🔬 Key areas for pharmaceutical technical staff include supervisory roles in Production (sterile/non-sterile), QC, and QA, as well as planning and procurement.
🏢 Pharmaceutical facility design mandates strict separation for sensitive categories like beta-lactams/cephalosporins, hormonal drugs, chemotherapy agents, and biological liquids (e.g., vaccines) to prevent cross-contamination.

Key Points & Insights
➡️ Pharmaceutical quality assurance (QA) requires personnel to have comprehensive knowledge of Production and QC, often needing a minimum of three years experience in these areas before becoming a QA Manager.
➡️ The concept of System Quality (in 2018 guidelines) is preferred over Management Quality, shifting focus from constant supervision to ingrained good habits across all stakeholders.
➡️ Drug quality must be proven, not just declared; QC sampling is representative and not 100% exhaustive, reinforcing the need for robust process validation (V&D).
➡️ For final drug products, critical defects (e.g., pharmacological impact like the Bupivacaine incident) necessitate recall and destruction, whereas minor defects might allow for reprocessing.

📸 Video summarized with SummaryTube.com on Feb 10, 2026, 12:10 UTC